WuXi Biologics: Spotlight On Property Disposal And Operating Metrics (Rating Upgrade)
WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...
pharmaphorum3d
MSD buys Irish vaccines plant from WuXi for €500m
MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...
pharmaphorum2d
Why Ireland has emerged as Europe’s biopharma hotspot
MSD has expanded its presence in Ireland with an agreement to buy a vaccines manufacturing facility from WuXi Biologics in Dundalk. Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm ...
Dundalk Democrat6d
What the state-of-art €325 million WuXi Biologics Dundalk plant may look like
If you want further access to Ireland's best local journalism ... The Investment Promotion & Development Agency (IDA) has revealed mock-up drawings of what the new WuXi Biologics plant in Dundalk ...
The Business Journals4d
WuXi moves ahead with new $510M campus in Delaware despite sale of Navy Yard operations
WuXi STA expects to hire about 500 people in the coming years to support Phase 1 of the manufacturing campus. A Chinese pharmaceutical company is moving forward with plans to build a massive $510 ...
Morningstar5d
China Pharma Group WuXi Gains as Trump's TikTok Move Buoys Mood
Its sister company WuXi Biologics rose 4.7%, while WuXi XDC, a contract medical research unit of WuXi Biologics, was up 5.0%. The WuXi companies have come under scrutiny amid tensions between the ...
Yahoo Finance2d
Samsung Biologics reports fourth quarter and fiscal year 2024 financial results
Samsung Biologics Logo (PRNewsfoto/Samsung Biologics) "2024 has been a year of steady progress for Samsung Biologics as we expanded collaboration with both pharma and biotech companies ...
Yahoo Finance4d
AbCellera Biologics Inc. (NASDAQ:ABCL) most popular amongst individual investors who own 36% of the shares, institutions hold 29%
Every investor in AbCellera Biologics Inc. (NASDAQ:ABCL) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 36% to be ...
Yahoo Finance3d
Samsung Biologics reports fourth quarter and fiscal year 2024 financial results
Samsung Biologics Logo (PRNewsfoto/Samsung Biologics) "2024 has been a year of steady progress for Samsung Biologics as we expanded collaboration with both pharma and biotech companies, supported by ...
ABC News3d
Ireland is finally set to get a new government, led by a familiar face
Veteran Irish politician Micheál Martin is set to become the country's prime minister for a second time DUBLIN -- Veteran politician Micheál Martin is set to become Ireland's prime minister for ...
Outsourcing-pharma3d
Bridgewest merges portfolio Australian CDMOs
Australian CDMOs, BioCina and NovaCina, have merged in a move to pool their biologic and small molecule production expertise ...